Global Bone and Joint Health Supplements Market Size, Share, and COVID-19 Impact Analysis, By Product (Vitamins, Minerals, Collagen, Omega-3, Glucosamine, and Others), By Formulation (Capsules, Tablets, Powders, Softgels, and Others), By Application (Food and Beverages, Pharmaceuticals, Dietary Supplements, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033
Industry: HealthcareGlobal Bone and Joint Health Supplements Market Insights Forecasts to 2033
- The Global Bone and Joint Health Supplements Market Size was Valued at USD 3.8 Billion in 2023
- The Market Size is Growing at a CAGR of 7.04% from 2023 to 2033
- The Worldwide Bone and Joint Health Supplements Market Size is Expected to Reach USD 7.5 Billion by 2033
- Asia-Pacific is expected to Grow the fastest during the forecast period.
Get more details on this report -
The Global Bone and Joint Health Supplements Market Size is Anticipated to Exceed USD 7.5 Billion by 2033, Growing at a CAGR of 7.04% from 2023 to 2033.
Market Overview
Vitamins, minerals, and other supplements play a role in keeping bones and joints healthy. Calcium is one of the most important minerals for bone health while vitamin D mediates calcium absorption, preventing osteoporosis, and promotes healthy functioning of muscles and the immune system. Vitamin C plays a significant role in immune functioning and helps with the formation of the protein collagen, which is essential for bone mineralization. Vitamin K is involved with the production of proteins in bone, including osteocalcin. Deficiency of these supplements leads to an increase in the risk of a fracture, which contributes to osteoporosis, the risk of fractures due to low bone density. Other supplements like fish oil/omega-3 fatty acids, glucosamine and chondroitin, and collagen are also contributing to bone and joint health. Glucosamine is one of the most popular supplements for arthritis which can delay cartilage breakdown, relieve osteoarthritis pain, and make joints more mobile. Supplements containing glucosamine and chondroitin are very popular and are sold as pain relievers for arthritis, and as treatments to reduce joint stiffness. Curcumin helps to cure both osteoarthritis and rheumatoid arthritis. Epigallocatechin gallate (EGCG) is a powerful antioxidant 100 times stronger than vitamin C and E. Omega-3 fatty acids help to cure the inflammatory symptoms of rheumatoid arthritis.
Report Coverage
This research report categorizes the market for the global bone and joint health supplements market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global bone and joint health supplements market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global bone and joint health supplements market.
Bone and Joint Health Supplements Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2023 |
Market Size in 2023: | USD 3.8 Billion |
Forecast Period: | 2023 - 2033 |
Forecast Period CAGR 2023 - 2033 : | 7.04% |
2033 Value Projection: | USD 7.5 Billion |
Historical Data for: | 2019-2022 |
No. of Pages: | 200 |
Tables, Charts & Figures: | 110 |
Segments covered: | By Product, By Formulation, By Application, By Region |
Companies covered:: | Amway, BASF SE, Bayer AG, The Procter & Gamble Company, Nature's Bounty, Herbalife International of America, Inc., GNC Holdings, LLC, BYHEALTH Co., Ltd., Vitalife Ltd, Glanbia plc, Archer Daniels Midland, and Others |
Pitfalls & Challenges: | Covid 19 Impact Challanges, Future, Growth and Analysis |
Get more details on this report -
Driving Factors
The changing lifestyle and eating habits have resulted in nutrient deficiency, which is expected to increase the consumption and demand for nutritional supplements. The rising geriatric population across countries such as Japan and Germany is among the critical demographics expected to propel the market as they are highly susceptible to bone injuries and fractures. The rising demand for herbal/natural bone and joint health supplements is also contributing to the market growth. Women are more prone to calcium deficiency thus there is an increasing need for bone supplements among the women population. Calcium supplements Boswellia can potentially reduce the adverse effects of calcium deficiency in women, like hypertensive conditions during pregnancy. Consequently, thus growing awareness about supplement consumption serves the growth of the calcium supplement market. The World Health Organization (WHO) estimated that almost 22 million individuals in Europe and 14 million in the United States alone would have osteoporosis. According to the National Library of Medicine, in 2021, it was observed that more than 1033 million people had osteoporosis. Thus rising cases of osteoporosis lead to enhanced market growth of bone and joint health supplements.
Restraining Factors
The high investment in R&D activity and the high cost of clinical trials of a bone and joint health supplement are responsible for hindering the market growth of bone and joint health supplements.
Market Segmentation
The global bone and joint health supplements market share is classified into product, formulation, and application.
- The vitamins segment dominates the market with the largest revenue share through the forecast period.
Based on the product, the global bone and joint health supplements market is categorized into vitamins, minerals, collagen, omega-3, glucosamine, and others. Among these, the vitamins segment dominates the market with the largest revenue share through the forecast period. The rising consumption of vitamin D supplements reduces the risk of bone fracture. Vitamin K is consumed for osteoporosis. Administration of calcium and vitamin D supplements is the main diet intervention against osteoporosis and is the key factor in achieving bone mass and reducing bone loss in infant, adult, and elderly patients.
- The capsules segment accounted for the largest market share in 2023.
Based on the formulation, the global bone and joint health supplements market is categorized into capsules, tablets, powders, soft gels, and others. Among these, the capsules segment accounted for the largest market share in 2023. Multilayered or multi-membrane encapsulations, extended-release capsules for vitamins and minerals, and omega-3 fatty acids are some of the products currently available in capsule formulations. Capsules are smoother and are easier to swallow. It breaks down faster than a tablet, for a quicker release time in the body.
- The dietary supplements segment is witnessing significant CAGR growth over the prediction period.
Based on the application, the global bone and joint health supplements market is categorized into food and beverages, pharmaceuticals, dietary supplements, and others. Among these, the dietary supplements segment is witnessing significant CAGR growth over the prediction period. The adoption of healthier lifestyle leads to enhanced market demand for dietary supplements. Further, the growing health awareness and disposable income of the consumer is responsible for the growing preference for dietary supplements.
Regional Segment Analysis of the Global Bone and Joint Health Supplements Market
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and the Rest of South America)
- The Middle East and Africa (UAE, South Africa, Rest of MEA)
North America is anticipated to hold the largest share of the global bone and joint health supplements market over the predicted timeframe.
Get more details on this report -
North America is projected to hold the largest share of the global bone and joint health supplements market over the forecast period. The growing geriatric population and rising number of people suffering from joint pain and arthritis contributing to the market growth of bone and joint health supplements. Further, the rising prevalence of micronutrient deficiencies among adults is also enhancing the market demand. In Canada, approximately 6 million people are diagnosed with arthritis. As per a survey conducted by NMI in the U.S., around 37% of supplement consumers are likely to use bone and joint health supplements. North America has a wealthy population and a developed healthcare system. Thus, the rising prevalence of bone and joint health disorders in the region leads to the enhancement of the market. The market for spine bone stimulators has expanded in the United States due to technological advancements.
Asia-Pacific is expected to grow at the fastest CAGR growth of the global bone and joint health supplements market during the forecast period. The rising awareness regarding health and well-being in the region promotes market demand. Further, the increasing prevalence of vitamin D deficiency and osteoporosis is also increasing the market growth. Additionally, the increasing disposable income and rising preference for maintaining health contribute to market growth in the region. The involvement of market players in strengthening industry growth is also contributing to the market growth.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the global bone and joint health supplements market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Amway
- BASF SE
- Bayer AG
- The Procter and Gamble Company
- Nature's Bounty
- Herbalife International of America, Inc.
- GNC Holdings, LLC
- BYHEALTH Co., Ltd.
- Vitalife Ltd
- Glanbia plc
- Archer Daniels Midland
- Others
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Developments
- In March 2023, FlexAgain to launch a Joint Supplement on 3rd party marketplaces such as Amazon.
-
In September 2023, Voltaren’s newest supplements support joint and bone health. Voltaren is rolling out two new products formulated with essential nutrients to support joint health and promote mobility and flexibility.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global bone and joint health supplements market based on the below-mentioned segments:
Global Bone and Joint Health Supplements Market, By Product
- Vitamins
- Minerals
- Collagen
- Omega-3
- Glucosamine
- Others
Global Bone and Joint Health Supplements Market, By Formulation
- Capsules
- Tablets
- Powders
- Softgels
- Others
Global Bone and Joint Health Supplements Market, By Application
- Food and Beverages
- Pharmaceuticals
- Dietary Supplements
- Others
Global Bone and Joint Health Supplements Market, Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East and Africa
Need help to buy this report?